About
Institut Curie, University of Versailles Saint-Quentin, Department of Medical Oncology and Gastrointestinal Oncology, Saint-Cloud
Most viewed articles
Pancreatic cancer: Current epidemiological knowledge and exploration of emerging environmental and occupational risk factors
- By Coralie Prévost,
- Matthieu Delaye,
- Cindy Neuzillet,
- et al.
In Hépato-Gastro & Oncologie Digestive (2026/4 Vol. 33)
Personalized therapy in digestive oncology
In Hépato-Gastro & Oncologie Digestive (2023/5 Vol. 30)
Co-authors
Articles
Pancreatic cancer: Current epidemiological knowledge and exploration of emerging environmental and occupational risk factors
- By Coralie Prévost,
- Matthieu Delaye,
- Cindy Neuzillet,
- et al.
In Hépato-Gastro & Oncologie Digestive (2026/4 Vol. 33)
Pancreatic cancer: Reasons for hope
In Hépato-Gastro & Oncologie Digestive (2025/9 Vol. 32)
Advanced cholangiocarcinomas: Second-line systemic therapies in the age of personalized medicine
- By Matthieu Delaye,
- Astrid Lièvre,
- Marine Jary,
- et al.
In Hépato-Gastro & Oncologie Digestive (2024/1 Vol. 31)
Systemic first-line treatment of advanced biliary tract cancers
- By Marine Jary,
- Éric Assenat,
- Matthieu Delaye,
- et al.
In Hépato-Gastro & Oncologie Digestive (2023/10 Vol. 30)
Metastatic pancreatic cancer: Other than cytotoxic chemotherapy, which therapies can be used?
In Hépato-Gastro & Oncologie Digestive (2023/7 Vol. 30)
Personalized therapy in digestive oncology
In Hépato-Gastro & Oncologie Digestive (2023/5 Vol. 30)
Metastatic intrahepatic cholangiocarcinoma: A “made-to-measure” treatment?
In Hépato-Gastro & Oncologie Digestive (2023/5 Vol. 30)